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Abstract
Background: HIV-infected individuals are at increased risk for acute and chronic airway disease
even though there is no evidence that the virus can infect the lung epithelium. Although HIV-related
proteins including gp120 and Tat can directly cause oxidant stress and cellular dysfunction, their
effects in the lung are unknown. The goal of this study was to determine the effects of HIV-1
transgene expression in rats on alveolar epithelial barrier function. Alveolar epithelial barrier
function was assessed by determining lung liquid clearance in vivo and alveolar epithelial monolayer
permeability  in vitro. Oxidant stress in the alveolar space was determined by measuring the
glutathione redox couple by high performance liquid chromatography, and the expression and
membrane localization of key tight junction proteins were assessed. Finally, the direct effects of the
HIV-related proteins gp120 and Tat on alveolar epithelial barrier formation and tight junction
protein expression were determined.
Results: HIV-1 transgene expression caused oxidant stress within the alveolar space and impaired
epithelial barrier function even though there was no evidence of overt inflammation within the
airways. The expression and membrane localization of the tight junction proteins zonula occludens-
1 and occludin were decreased in alveolar epithelial cells from HIV-1 transgenic rats. Further,
treating alveolar epithelial monolayers from wild type rats in vitro with recombinant gp120 or Tat
for 24 hours reproduced many of the effects on zonula occludens-1 and occludin expression and
membrane localization.
Conclusion: Taken together, these data indicate that HIV-related proteins cause oxidant stress
and alter the expression of critical tight junction proteins in the alveolar epithelium, resulting in
barrier dysfunction.
Background
Individuals infected with the human immunodeficiency
virus (HIV) are susceptible to both routine and opportun-
istic infections of the lung. Despite the advent of highly
active anti-retroviral therapy (HAART), lung disease con-
tinues to be the leading cause of death [1,2]. Interestingly,
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although infections account for the apparent majority of
these lung-related deaths, there is growing evidence that
HIV also increases the risk of chronic airway diseases such
as emphysema. For example, an analysis of the Veterans
Aging Cohort Study showed that HIV-infected subjects
were 50–60% more likely to develop chronic obstructive
pulmonary disease (emphysema and/or chronic bronchi-
tis) than HIV-negative subjects, and that HIV infection
was an independent risk factor even after accounting for
age, race/ethnicity, smoking histories, and substance
abuse [3]. Other studies show similar results and several
recent excellent reviews summarize the clinical data to
date as well as some of the laboratory-based research that
is beginning to explore possible mechanisms [4-6]. A
common target in both acute lung injuries such as pneu-
monia and chronic lung diseases such as emphysema is
alveolar epithelial damage. However, whether or not
chronic HIV infection renders the alveolar epithelium sus-
ceptible to injury is unknown.
There is abundant evidence that oxidant stress is associ-
ated with a wide range of lung diseases [7,8]. Within the
alveolar space, the thiol antioxidant glutathione (GSH)
plays a key role in detoxifying endogenous and exogenous
oxidants and limits the oxidation of cysteine residues in
many proteins, thereby regulating redox signaling [9,10].
The preservation of an adequate GSH pool within the
alveolar space is therefore critical to control cell signaling,
the transcription of pro-inflammatory genes, cell prolifer-
ation and survival [7,8,11]. Unfortunately, HIV infection
is associated with significant oxidant stress and decreased
systemic levels of GSH [12-14]. Within the lung, there is
evidence that GSH levels decline as the disease progresses,
whereas the lungs of asymptomatic individuals have pre-
served levels of GSH [15,16].
Importantly, not all of the consequences of HIV infection
can be attributed solely to direct viral infection. It has
been reported that HIV-related proteins released by
infected cells can enter the central nervous system (CNS)
from the blood and affect CNS function independently of
viral transport [17]. For example, the HIV envelope pro-
tein, gp120, and the transregulatory protein Tat, can stim-
ulate endothelial cells to secrete neuro-immunoactive
substances [17]. It is interesting to note that gp120 and Tat
can directly induce oxidant stress and GSH depletion in
isolated endothelial cells, and this appears to contribute
to tight junction disruption and compromise of the
blood-brain barrier [18,19]. Although the mechanisms by
which these HIV-related proteins cause oxidant stress are
not completely understood, it has been shown that Tat
can repress the expression of the mitochondrial form of
superoxide dismutase in HeLa cells [20]. Whether this
repression of superoxide dismutase or some other oxidant
stress induced by these proteins decreases the intracellular
GSH pool is unclear. Transgenic animal studies extend
such in vitro studies and provide perhaps the most com-
pelling evidence implicating HIV-related proteins in the
pathophysiology of the disease [21]. Reid and colleagues
established a non-infectious HIV-1 transgenic (HIV-1 Tg)
rat model that expresses an HIV-1 provirus regulated by
the viral promoter but with a functional deletion of gag
and pol [22,23]. This HIV-1 Tg rat develops a progressive
AIDS-like phenotype as it ages including immunologic
dysfunction, nephropathy, muscle wasting, skin lesions
and cataracts [22,23]. We recently reported that these HIV-
1 transgenic rats have soluble gp120 in their alveolar epi-
thelial lining fluid and have significant defects in alveolar
macrophage immune function [10]. These findings were
provocative as they suggest that the well-known effects of
HIV infection on this resident immune cell within the
alveolar space may not be entirely due to viral infection
and replication per se, but that HIV-related proteins could
exert pathophysiological effects within this microenviron-
ment. Further, although the effects of HIV infection on
alveolar macrophage function have been studied exten-
sively, very little attention has focused on possible effects
on the alveolar epithelium as this cell type is not infected
by the virus. However, as HIV-related proteins are present
in the alveolar space during chronic infection and have
toxic effects on other cell types that are likewise not
infected directly by the virus, and because HIV-infected
individuals are also susceptible to diseases associated with
alveolar epithelial dysfunction, we investigated the effects
of HIV-1 transgene expression on alveolar epithelial func-
tion in the rat model. In this study, we report that chronic
expression of HIV-related proteins in vivo causes profound
oxidant stress and GSH depletion in the lung. In parallel,
these HIV-related proteins cause significant alveolar epi-
thelial barrier dysfunction that is associated with changes
in tight junction proteins that can be reproduced in pri-
mary alveolar epithelial cells in vitro by direct exposure to
gp120 and Tat. Taken together, these results provide the
first evidence that HIV-related proteins affect alveolar epi-
thelial barrier function and could thereby render infected
individuals susceptible to acute or chronic causes of respi-
ratory failure.
Results
HIV-1 transgene expression caused significant oxidant 
stress in the lung
We first determined the relative levels of glutathione
(GSH) and its primary oxidized form, glutathione
disulfide (GSSG) in the lung lavage fluids of wild type
(WT) and HIV-1 transgenic (HIV-1 Tg) rats. As shown in
Figure 1, panel A, GSH levels were decreased >90% (P =
0.0016) in HIV-1 Tg rats compared to WT rats. In parallel,
there was evidence of significant GSH oxidation; specifi-
cally, and as shown in Figure 1, panel B, the relative levels
of glutathione disulfide (GSSG; the predominant form ofAIDS Research and Therapy 2009, 6:1 http://www.aidsrestherapy.com/content/6/1/1
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oxidized glutathione) to GSH, expressed as the
GSSG:GSH ratio (a commonly used index of oxidant
stress), were increased nearly 3-fold (P = 0.0049) in HIV-
1 Tg rats compared to WT rats. Further evidence of oxidant
stress in the lungs of HIV-1 Tg rats is shown in Figure 2.
Lung tissue levels of hydrogen peroxide were significantly
increased (P < 0.0001) in HIV-1 Tg rats compared to WT
rats. In contrast, despite the oxidant stress within the alve-
olar space of HIV-1 transgenic rats, there was no evidence
of significant inflammation. Specifically, the cell counts
and differentials were not different (P > 0.05) in the lung
lavage fluids of HIV-1 transgenic rats when compared to
wild type rats (Table 1; shown are the mean values ± SEM
of 4 rats in each group; for the differential counts, an aver-
age of 525 cells per lavage fluid sample were analyzed. In
parallel, the levels of interleukin-2 (IL-2), tumor necrosis
factor-α (TNFα) and interleukin-4 (IL-4) were the same (P
> 0.05) in the lung lavage fluids of HIV-1 transgenic rats
when compared to wild type rats (Table 2; shown are the
mean values ± SEM of 4 rats in each group; note the trend
toward an increase in IL-2 in the HIV-1 transgenic rats but
with significant variation in the levels of this cytokine).
Although these latter results do not exclude perturbations
in the control of inflammation within the alveolar space,
they nevertheless suggest that chronic expression of HIV-
1-related proteins causes significant oxidant stress but this
is not accompanied by overt chronic inflammation. This
is consistent with our previous findings that HIV-1 trans-
genic expression dampens the immune functions of the
resident alveolar macrophage [10]. These findings are also
consistent with the effects of chronic alcohol ingestion on
the lung, which causes significant glutathione depletion
within the alveolar space but does not by itself cause overt
lung inflammation or injury [24-26].
HIV-1 transgene expression impaired alveolar epithelial 
barrier function
To investigate epithelial barrier function in vivo, we exam-
ined lung liquid clearance following intra-tracheal saline
challenge as we have previously described [27,28]. This
technique provides a sensitive index of overall lung epi-
thelial barrier function, which is the integration of active
fluid transport and paracellular permeability. As shown in
Figure 3, panel A, wet:dry ratios in HIV-1 Tg rats following
saline challenge were increased ~2-fold higher above
baseline than comparably challenged WT rats (P < 0.05),
reflecting a significantly decreased ability to clear saline
from the lung. Note that the baseline wet:dry ratio of the
rat lung is 4.7 as we have published previously [27], and
therefore the data are plotted to reflect the relative
increases from this baseline in each group. As decreased
lung liquid clearance can reflect either an increase in epi-
thelial paracellular permeability or a decrease in transcel-
lular fluid transport, we next determined alveolar
epithelial paracellular permeability in vitro. We have used
and published this combination of lung liquid clearance
in vivo and alveolar epithelial paracellular permeability in
vitro to examine the effects of chronic alcohol ingestion on
the alveolar epithelial barrier [27,28]. As shown in Figure
3, panel B, alveolar epithelial monolayers derived from
HIV Tg rats had an ~3-fold increase (P < 0.05) in paracel-
lular permeability, as reflected by 3H-sucrose flux in 2 hrs,
when compared to alveolar epithelial monolayers derived
from WT rats. Therefore, the defect in lung liquid clear-
ance shown in Figure 3, panel A appears to be due at least
in part to a relative increase in alveolar epithelial permea-
bility induced by HIV-1 transgene expression. Impor-
tantly, these effects on the alveolar epithelial barrier could
not be explained by transgene expression of HIV-related
proteins within the alveolar epithelium per se, as gp120
expression was not detected in these cells by ELISA (not
shown), even though gp120 protein was easily detectable
in even dilute lung lavage fluid in our previous study [10].
This is consistent with the clinical scenario, where HIV
does not infect the lung epithelium but can be found
along with its related proteins within the alveolar space
[29].
HIV-1 transgene expression was associated with 
alterations in the tight junction proteins zonula occludens-
1 and occluding
As tight junction proteins mediate the ability of alveolar
epithelial cells to regulate paracellular permeability [30],
we extended the physiological studies shown in Figure 3
and examined the effects of HIV-1 transgene expression
on two key tight junction proteins, namely zonula occlu-
dens-1 (ZO-1) and occludin, in the alveolar epithelium.
As shown in Figure 4, panel A, gene expression for both
ZO-1 and occludin were decreased significantly (P <
0.05), albeit modestly, by alveolar epithelial cells from
Table 1: Comparison of total cells and differential cell counts from rat BAL between wild type and HIV-1 transgenic rats.
Cell type
Group Total cells (×106) Macrophages (%) Lymphocytes (%) Neutrophils (%)
Wild Type 1.96 ± 0.2 97.92 ± 0.7 1.61 ± 0.5 0.47 ± 0.2
HIV-1 Tg 2.36 ± 0.1 97.27 ± 0.2 1.90 ± 0.2 0.82 ± 0.2AIDS Research and Therapy 2009, 6:1 http://www.aidsrestherapy.com/content/6/1/1
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HIV-1 Tg rats when compared to alveolar epithelial cells
from WT rats. These modest inhibitions of gene expres-
sion were nevertheless associated with decreases in pro-
tein expression. As shown in Figure 4, panel B, both ZO-1
and occludin protein expression were significantly
decreased (P < 0.05) in alveolar epithelial cells from HIV-
1 Tg rats when compared to alveolar epithelial cells from
WT rats, both in the membrane/cytoskeleton (Triton X-
100 insoluble) and the cytosol (Triton X-100 soluble)
fractions. As paracellular permeability depends not only
on tight junction protein expression but also their correct
localization within the plasma membrane, we next exam-
ined ZO-1 and occludin in alveolar epithelial cell monol-
ayers by fluorescent immunocytochemistry. As shown in
the representative images in Figure 4, panel C, the relative
distribution of ZO-1 and occludin was less uniform in the
plasma membranes of monolayers derived from HIV-1 Tg
rats, and also showed more granular staining within the
cytoplasm of the cells. These findings were particularly
striking for ZO-1 (upper two panels). The magnification
bar in the lower right image = 100 microns.
Treatment of alveolar epithelial cell monolayers from wild 
type rats with the HIV-related proteins gp120 or Tat in 
vitro altered expression of occludin and ZO-1
To determine whether or not HIV-related proteins, partic-
ularly gp120 and Tat, could be implicated more directly in
the observed changes in ZO-1 and occludin expression,
we exposed alveolar epithelial monolayers from wild type
(WT) rats (6–7 days in culture) to recombinant gp120 or
Tat for 24 hrs and then assessed the expression of these
tight junction proteins. As shown in Figure 5, panel A,
treatment with either gp120 or Tat significantly (P < 0.05)
decreased both occludin and ZO-1 gene expression by
~20% and 30% respectively compared to no treatment
(control). In contrast, treatment with heat-inactivated
gp120 had no effect on either occludin or ZO-1 gene
expression (not shown). Although this short-term expo-
sure did not reproduce the entire pattern of ZO-1 and
occludin protein expression seen in monolayers from
HIV-1 Tg rats, Tat treatment decreased (P < 0.05) both ZO-
1 and occludin protein levels in the membrane/cytoskele-
ton (Triton X-100 insoluble) fraction when compared to
no treatment (control) as shown in Figure 5, panel B (* P
< 0.05 compared to control in each condition). In paral-
Table 2: Comparison of pro- and anti-inflammatory cytokines 
from BAL in wild type and HIV-1 transgenic rats.
Wild Type HIV-1 Tg
IL-2 (pg/ml) 20.2 ± 10.8 98.5 ± 58.9
TNFα (pg/ml) 0.5 ± 0.2 1.1 ± 0.3
IL-4 (pg/ml) 4.4 ± 1.1 6.4 ± 1.2
HIV-1 transgene expression decreased glutathione levels and altered the glutathione redox balance in the alveolar space Figure 1
HIV-1 transgene expression decreased glutathione levels and altered the glutathione redox balance in the 
alveolar space. Lung lavage fluid from HIV-1 transgenic (HIV-1 Tg) rats had significantly decreased (* P = 0.0016) levels of glu-
tathione (GSH) as shown in panel A, and significantly increased (* P = 0.0049) ratios of glutathione disulfide (GSSG; the pre-
dominant form of oxidized glutathione) to GSH as shown in panel B, when compared to lung lavage fluid from wild type (WT) 
rats. The levels of GSH and GSSG were determined by HPLC as described in the Methods. Each value represents the mean ± 
SEM of 4 rats.AIDS Research and Therapy 2009, 6:1 http://www.aidsrestherapy.com/content/6/1/1
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lel, immunocytochemical analyses revealed changes in
occludin and ZO-1 staining in the plasma membranes of
gp120- and Tat-treated monolayers that were similar to
those seen in monolayers from HIV-1 Tg rats shown in
Figure 4C. Specifically, as shown in the representative
images in Figure 5 (panel C shows staining for ZO-1 and
panel D shows staining for occludin), treatment with
either gp120 or Tat caused some discontinuous staining
within the plasma membranes and appeared to increase
the amount of punctate staining within the cytosol. The
magnification bar in the lower right image of each panel
= 100 microns. Therefore, even short-term treatment of
naïve alveolar epithelial monolayers with gp120 or Tat in
vitro  produced changes in the expression of ZO-1 and
occludin that were consistent with what was observed in
the alveolar epithelium of rats that expressed these pro-
teins in vivo.
Discussion
In this study we determined that HIV-1 transgene expres-
sion in rats, in which HIV-related proteins including
gp120 and Tat are expressed in the absence of viral infec-
tion or replication, causes significant oxidant stress and
alveolar epithelial barrier dysfunction in the lung. Specif-
ically, the pool of glutathione within the alveolar space of
HIV-1 Tg rats was decreased >90%, with a concomitant
increase in the ratio of oxidized to reduced glutathione, as
well as an increase in tissue levels of hydrogen peroxide.
However, despite this significant oxidant stress there was
no overt evidence of lung inflammation as reflected by the
absence of neutrophil or lymphocyte infiltration of the
airways and no change in the levels of several key
cytokines. In parallel with the oxidant stress the alveolar
epithelial barrier was impaired, with decreased lung liq-
uid clearance in vivo that correlated with increased para-
cellular permeability of alveolar epithelial monolayers in
vitro. Finally, the expression and membrane localization
of two key tight junction proteins, ZO-1 and occludin,
were decreased within the alveolar epithelium of HIV-1 Tg
rats, consistent with previous findings that Tat alters ZO-1
expression in the blood-brain barrier via redox-sensitive
signaling mechanisms [31]. Finally, these effects on ZO-1
and occludin expression could be largely reproduced by
treating naïve alveolar epithelial monolayers with gp120
or Tat protein directly in vitro. Taken together, these results
indicate that HIV-related proteins produce oxidant stress
and previously unrecognized barrier dysfunction within
the alveolar epithelium, effects that resemble toxicities
that have been described in other tissues such as the
endothelium of the blood-brain barrier [32,33]. Further,
these results suggest a novel mechanism by which HIV
infection might render individuals susceptible to acute
and chronic forms of respiratory failure. For example, an
impaired alveolar epithelial barrier would increase lung
edema and worsen gas exchange during acute pneumonia,
and could potentially increase the susceptibility to
chronic damage from smoking and promote the develop-
ment of emphysema. When these effects on the alveolar
epithelium are coupled with the immune suppression of
alveolar macrophages that we recently described in this
model [10], the experimental evidence argues that chronic
exposure of the alveolar epithelium to HIV-related pro-
teins in vivo could contribute to the increased risk of acute
and chronic lung disease in HIV-infected individuals.
Many lung disorders are associated with oxidant stress
[11], and it is not surprising that HIV infection has long
been recognized to cause systemic and pulmonary oxi-
dant stress, including significant lowering of glutathione
levels [12-15]. Our findings in this study provide compel-
ling evidence that HIV-related proteins exert oxidant stress
within the alveolar space independently of active viral
replication. Further, as the levels of glutathione were
decreased by ~90% in the lung lavage fluid (which largely
reflects the alveolar epithelial lining fluid), these results
suggest that the alveolar compartment is particularly vul-
nerable to oxidant damage during HIV infection. The
investigation of the mechanisms by which these HIV-
related proteins induce oxidant stress within the alveolar
space was beyond the scope of this initial study. Whether
or not putative mechanisms that have been implicated
with individual HIV-related proteins such as gp120 or Tat
in cell culture studies in vitro are involved in the alveolar
space in vivo is at present unknown. However, these find-
ings suggest the possibility that therapeutic strategies
HIV-1 transgene expression increased the levels of hydrogen  peroxide levels in lung tissue Figure 2
HIV-1 transgene expression increased the levels of 
hydrogen peroxide levels in lung tissue. Lung tissue 
from HIV-1 transgenic (HIV-1 Tg) rats had significantly 
increased (* P < 0.0001) levels of hydrogen peroxide (H2O2) 
compared to lung tissue from wild type (WT rats). H2O2 lev-
els were determined by the Amplex Red fluorescent detec-
tion technique as described in the Methods. Each value 
represents the mean ± SEM of 6 rats.AIDS Research and Therapy 2009, 6:1 http://www.aidsrestherapy.com/content/6/1/1
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designed to augment glutathione pools within the airway
could mitigate the effects of chronic HIV infection.
The potential for complementing current HAART strate-
gies with antioxidant supplements is further supported by
emerging evidence that the oxidant stress caused by
chronic HIV infection could be exacerbated by other fac-
tors such as alcohol abuse, which is a common co-morbid
condition in this population [34,35]. Our group has used
both animal models and clinical studies to demonstrate
that chronic alcohol abuse also causes oxidant stress
within the alveolar space [24,26], as well as alveolar epi-
thelial [24,36,37] and macrophage defects [9,38-40] that
are remarkably similar to what we have identified in the
HIV-1 transgenic rat model, including altered expression
and membrane localization of tight junction proteins
[41]. Therefore, chronic alcohol ingestion could exacer-
bate HIV-mediated oxidant stress as well as epithelial and
endothelial barrier dysfunction, and could thereby
account for the poorer outcomes in these individuals [34].
It can be difficult to extrapolate from animal models and
separate association from causation in complex human
diseases, and to date the evidence supporting the clinical
use of anti-oxidants as a treatment for a specific lung dis-
ease is lacking. However, the combination of HIV infec-
tion and chronic alcohol abuse may represent a uniquely
vulnerable population that could respond to dietary sup-
plements with glutathione precursors, such as S-adenosyl-
methionine. In addition, we recently determined that
HIV-1 transgene expression impairs zinc homeostasis
within the alveolar space, and that dietary zinc supple-
mentation improves alveolar macrophage immune func-
tion [10].
There are limitations in this initial study. We did not
examine other potential contributors to the oxidant stress
such as alterations in nitric oxide balance ("nitrosative
stress"). In addition, our evaluation of potential dysregu-
lation of inflammation within the alveolar space was
restricted to quantification of inflammatory cells and
three key cytokines; although we found no gross evidence
of inflammation in the airways of HIV-1 transgenic rats,
we clearly did not exclude important changes such as
alterations in lymphocyte subsets or other perturbations.
In light of the significant dampening of alveolar macro-
phage immune function that we previously identified in
HIV-1 transgene expression impaired alveolar epithelial barrier function in vivo and increased permeability of alveolar epithelial  monolayers in vitro Figure 3
HIV-1 transgene expression impaired alveolar epithelial barrier function in vivo and increased permeability of 
alveolar epithelial monolayers in vitro. Panel A shows the relative lung liquid clearance, as reflected by lung tissue wet:dry 
ratios 30 min following intratracheal challenge with 2 cc of saline (see Methods for details), in wild type (WT) vs. HIV-1 trans-
genic (HIV-1 Tg) rats. The wet:dry ratios in HIV-1 Tg rats were increased ~2-fold higher above baseline than WT rats (* P < 
0.05), reflecting a significantly decreased ability to clear saline from the lung. Note that the baseline wet:dry ratio of the rat lung 
is 4.5, and therefore the data are plotted to reflect the relative increases from this baseline in each group. Each value repre-
sents the mean ± SEM of 6 rats. Panel B shows the relative paracellular permeability of alveolar epithelial monolayers derived 
from WT vs. HIV-1 TG rats, as reflected by the flux of 3H-sucrose across each monolayer in 2 hrs (see Methods for details). 
Alveolar epithelial monolayers derived from HIV-1 Tg rats had an ~3-fold increase (* P < 0.05) in paracellular permeability 
when compared to alveolar epithelial monolayers derived from WT rats. Each value represents the mean ± SEM of alveolar 
epithelial monolayers from 6 rats.AIDS Research and Therapy 2009, 6:1 http://www.aidsrestherapy.com/content/6/1/1
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this model [10], one might expect to see impaired recruit-
ment of neutrophils and/or appropriate lymphocyte sub-
sets during stresses such as pneumonia. Another
important limitation of this study is that at present we
cannot conclude that the effects of chronic exposure to
HIV-1-related proteins in the rat lung mirror the effects in
the lungs of HIV-infected humans. Importantly, whether
or not human or non-human cells are used to study the
effects of these proteins on cells in vitro, it remains prob-
lematic to extend such findings to the clinical setting.
Therefore, our findings in this transgenic rat model can
serve as a guide in designing clinical studies but must be
confirmed in the human context. Although these experi-
mental findings need to be translated to the clinical set-
ting, it is compelling to consider that glutathione
precursors and zinc could be adjunctive therapies in the
chronic treatment regimens for HIV infection. Such strat-
egies could be applied fairly easily to determine if the alve-
HIV-1 transgene expression altered the expression of two key components of alveolar epithelial tight junctions, occludin and  zonula occludens-1 (ZO-1) Figure 4
HIV-1 transgene expression altered the expression of two key components of alveolar epithelial tight junc-
tions, occludin and zonula occludens-1 (ZO-1). Alveolar epithelial cells from HIV-1 Tg rats had significantly decreased (* 
P < 0.05) gene expression of both occludin and ZO-1 (Panel A; each value represents the mean ± of 6 determinations). In par-
allel, alveolar epithelial cells from HIV-1 Tg rats had significantly decreased (* P < 0.05) protein expression of occludin and ZO-
1 in both the membrane/cytoskeleton (Triton X-100 insoluble) and the cytosol (Triton X-100 soluble) fractions (Panel B; 
shown are the summary data expressed as the mean ± SEM of 6 determinations as well as representative immunoblots for 
each group). Panel C shows representative fluorescent immunocytochemistry images, and illustrates that the relative distribu-
tion of ZO-1 and occludin was less uniform in the plasma membranes of alveolar epithelial monolayers derived from HIV-1 Tg 
rats when compared to monolayers from WT rats, and also showed more granular staining for each protein within the cyto-
plasm of the cells. These findings were particularly striking for ZO-1 (upper two panels). The magnification bar in the lower 
right image = 100 microns.AIDS Research and Therapy 2009, 6:1 http://www.aidsrestherapy.com/content/6/1/1
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olar macrophage dysfunction we identified in this
experimental model [10] does indeed translate to the clin-
ical setting. For example, if dietary zinc and/or glutath-
ione supplements improved alveolar macrophage
function in otherwise healthy HIV-infected individuals (it
is not feasible to obtain sufficient quantities of alveolar
epithelial cells), this would provide additional validation
of the transgenic rat model and more importantly would
provide the rationale for a multi-center interventional
trial.
Conclusion
In summary, we report that HIV-1 transgene expression
causes previously unrecognized oxidant stress within the
alveolar space, and that this oxidant stress is associated
with changes in tight junction protein expression and bar-
rier dysfunction in the alveolar epithelium even in the
Treatment of alveolar epithelial monolayers from wild type rats with either gp120 or Tat for 24 hrs altered expression of  occludin and ZO-1 Figure 5
Treatment of alveolar epithelial monolayers from wild type rats with either gp120 or Tat for 24 hrs altered 
expression of occludin and ZO-1. Treatment with either gp120 or Tat significantly decreased (P < 0.05) the gene expres-
sion of occludin and Tat when compared to untreated control cells (Panel A). Although occludin and ZO-1 protein expression 
were either unchanged or increased (* P < 0.05) in the cytosol (Triton X-100 soluble) fractions (Panel B, left side) following 
these short-term exposures, Tat treatment significantly decreased (*P < 0.05) both occludin and ZO-1 protein expression in 
the membrane/cytoskeleton (Triton X-100 insoluble) fractions (panel B, right side). In parallel, and consistent with the images 
shown in Figure 4, treatment with either gp120 or Tat altered the membrane localization of occludin and ZO-1. Shown in pan-
els C and D are representative fluorescent immunocytochemistry images illustrating that the relative distribution of ZO-1 
(Panel C) and occludin (Panel D) was less uniform in the plasma membranes of gp120-treated or Tat-treated alveolar epithelial 
monolayers compared to untreated (control) monolayers, with more granular staining for each protein within the cytoplasm of 
the cells. The magnification bar in the lower right image of each panel = 100 microns.AIDS Research and Therapy 2009, 6:1 http://www.aidsrestherapy.com/content/6/1/1
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absence of any obvious airway inflammation. Although
previous studies have determined that HIV-related pro-
teins induce oxidant stress and disrupt the blood-brain
endothelial barrier with significant consequences to the
central nervous system [19,33,42], to our knowledge there
are no studies to date that demonstrate comparable toxic-
ities within the alveolar epithelium. These findings are
provocative in that they suggest a novel mechanism by
which HIV infection renders individuals susceptible to
acute and chronic forms of lung injury, and in particular
could help explain how HIV infection increases the risk of
putatively non-infectious lung diseases such as emphy-
sema [3-5,43]. Finally, this study and recent work from
our laboratory [10,44] suggest that HIV-1 transgenic
rodent models offer unique opportunities to determine
the pathological effects of HIV-related proteins independ-
ently of viral infection and/or replication, and provide
powerful tools to perform pre-clinical assessment of com-




Male HIV-1 transgenic Fischer 344 rats and Fischer 344
wild type rats were purchased from Harlan (Indianapolis,
Indiana) and bred in the animal facility at the Atlanta VA
under a 12:12 light-dark cycle. The transgenic rat is
hemizygous NL4-3Δgag/pol, in which the 3' region of gag
and the 5' region of pol is deleted [23]. Therefore, breeding
pairs produce off-spring that are ~50% HIV-1 transgenic
and ~50 wild type (confirmed by genotyping), allowing
the use of littermate wild type animals as controls. The
HIV-1 transgenic rats have dense cataracts at birth but oth-
erwise appear healthy and develop normally; however, by
6 months of age they begin to display evidence of systemic
disease including poor weight gain and muscle atrophy
that progress over time. In these studies, we used HIV-1
transgenic rats and their wild type littermates between the
ages of 7 and 9 months. Food and water were provided ad
libitum. All procedures were approved by the Atlanta Vet-
eran Affairs Medical Center Institutional Animal Care and
Use Committee.
Analyses of lung lavage fluid for total and differential cell 
counts, cytokine levels, and glutathione (GSH) and 
glutathione disulfide (GSSG) determinations
Bronchoalveolar lavage (BAL) fluid samples (n = 4) were
assessed for 1) cell counts using a standard hemocytome-
ter (total counts) and manual counting of cells stained
with Wright's stain and analyzed under low power with a
light microscope, 2) levels of IL-2, TNFα, and IL-4 using a
Luminex assay (Linco Research Inc., MO) following the
manufacturer's instructions, and 3) GSH and GSSG levels
by derivatizing the fluid with iodoacetic acid and dansyl
chloride and analyzing by HPLC with fluorescence detec-
tion [45]. GSH and its dominant oxidized form glutath-
ione disulfide (GSSG) were quantified by integration
relative to an internal standard [45]. The levels of GSH
(the predominant component of the redox couple under
normal conditions) were expressed in mM concentrations
in the lavage fluids. In parallel, the relative concentrations
of GSSG to GSH in the lavage fluids were expressed as the
GSSG:GSH ratios, which is a standard method of assessing
oxidation of the GSH redox couple in biological fluids
[45].
Lung tissue hydrogen peroxide analysis
As previously described [44], lung tissue (n = 6) was iso-
lated and hydrogen peroxide was quantified using the
Amplex Red reagent (Molecular Probes, OR), a highly sen-
sitive and stable probe utilized as a fluorogenic substrate
for horseradish peroxidase. Briefly, lung tissue was iso-
lated and incubated at 37°C for 30 minutes in solution
containing Amplex Red reagent, horseradish peroxidase,
and a buffer solution. Supernatant was then collected, and
fluorescence was read at 560 nm. Concentrations were
determined using extrapolation of a standard curve.
Lung liquid clearance in vivo
We used a method we have published previously [27,28].
Rats were anesthetized with sodium pentobarbital and a
tracheostomy cannula was introduced. A saline solution
(2 mL) was introduced into the trachea, and the rats were
mechanically ventilated for 30 minutes. Ventilation was
performed using a Harvard rodent ventilator with a tidal
volume of 2.5 mL (~8 mL/kg body weight) at a rate of 60
breaths/min for 30 minutes. After 30 minutes of ventila-
tion, a median sternotomy was performed, and the right
lung was excised and weighed to obtain the wet weight.
The lung was then dehydrated overnight at 70°C and the
dry weight was then determined. The ratio of the wet
weight to dry weight was calculated and expressed for each
lung sample.
Alveolar epithelial monolayer culture and treatments
Alveolar epithelial type II cells (AEC) were isolated from
HIV-1 transgenic and control rats using a previous proto-
col [46]. Briefly, rats were anesthetized, and a tracheos-
tomy was placed followed. The lungs were perfused
blood-free with saline via the pulmonary artery and after
en bloc isolation were filled via the tracheostomy cannula
with a solution containing porcine pancreatic elastase.
The lung parenchyma was then isolated from the large air-
ways and minced, and then successively filtered through
100- and 20-μM nylon mesh. The recovered cells were
plated onto plastic dishes pre-coated IgG to remove the
alveolar macrophages and other immune cells. After 1 h
of incubation at 37°C, the non-adherent cells were gently
aspirated from the plates. Cells obtained by this method
contained ~90% AEC that are >90% viable by trypan blueAIDS Research and Therapy 2009, 6:1 http://www.aidsrestherapy.com/content/6/1/1
Page 10 of 12
(page number not for citation purposes)
exclusion. Freshly isolated AEC were then re-suspended.
In selected experiments, cells were assessed for the expres-
sion of the HIV-1-related proteins gp120 and Tat by ELISA
and western blot analysis, respectively. Cells were plated
using 300,000 cells per ml onto 12 mm diameter perme-
able membranes (0.4 μM pore, Corning) and cultured for
a total of 8 days at 37°C in 90% air-10% CO2. The
medium was changed every 48 hours. To determine the
independent and direct effects of HIV-1-related proteins
on alveolar epithelial tight junction proteins, 6 day AEC
monolayer cultures from wild type rats were treated with
either gp120 (100 ng/ml, ImmunoDiagnostics, MA) or
Tat (1 μg/ml, ImmunoDiagnostics, MA) in serum free
medium for 24 hrs at 37°C, and then ZO-1 and occludin
mRNA and protein expression were assessed by real-time
PCR and western blot analyses, respectively. In parallel,
the specificity of gp120-induced effects was also assessed
by treating some monolayers with heat-inactivated gp120
(incubated at 85°C for 30 min).
Alveolar epithelial permeability assay
The barrier function of the cell monolayers after 7 days in
culture was determined as we have done previously [36]
by determining the percent flux of 3H-labeled sucrose
across AEC monolayers cultured in transwells which con-
tained the media covering the apical surfaces of the cul-
tured cells. Permeability was defined as the fraction of the
initial radioactivity placed on the apical surface that
appeared on the basolateral surface of the monolayer after
2 hours, and expressed as a percentage. We have previ-
ously shown that this method correlates well with radiola-
beled inulin flux across these monolayers, and with the
flux of radiolabeled albumin flux across the alveolar epi-
thelial barrier in vivo [36].
Western analyses
Cultured AEC were washed with cold PBS, lysed in Triton
X-100 buffer (25 mM Hepes/NaOH (pH7.4), 150 mM
NaCl, 4 mM Na2EDTA, 25 mMNaF. 1%Triton X-100, 1
mM Na3VO4, 1 mM PMSF and protease inhibitor cocktail
(Roche)) on ice for 30 min and then centrifuged at 14,000
g for 10 min. The supernatants were collected as the Triton
X-100 soluble fraction represented cytosolic fraction. The
pellets were re-suspended in SDS lysis buffer (25 mM
HEPES/NaOH (pH7.4), 4 mM Na2EDTA, 25 mM NaF.
1%Triton X-100, 1 mM Na3VO4), sonicated, boiled for 5
min and centrifuged for 10 min at 14,000 g. The superna-
tant was used as the Triton X-100 insoluble fraction repre-
sented most membrane/cytoskeleton fraction [47,48].
The protein concentration was determined by the BCA
method. An equal amount of protein (15–50 μg) was sep-
arated on 8% SDS polyacrylamide gel and transferred to
PVDF membrane. After blocking with 5% milk/TBST, the
membrane was incubated with anti-zonula occludens-1
(ZO-1) or anti-occludin antibody (Invitrogen) overnight
and then corresponding HRP-conjugated 2nd antibody
was added prior to ECL plus substrate (GE healthcare).
The immunoreactive bands were captured with Chemi-
Doc XRS system (Bio-Rad). Same membrane was stripped
and incubated for anti-actin antibody (Santa Cruz bio-
technology, Inc., Santa Cruz).
Immunocytofluorescence
Freshly isolated AEC were cultured on glass coverslips for
7 days as we have published previously [41]. Briefly, the
monolayers were washed with PBS, fixed and permeabi-
lized with methanol/acetone 1:1 for 2 min, and then
washed with PBS + 0.5% Triton X-100 (PBS/TX) and incu-
bated with PBS + 0.5% Triton X-100 + 2% goat serum
(PBS/TX/GS). The primary antibody was diluted in PBS +
2% goat serum (PBS/GS) and then added on cell layers for
1 hr at room temperature prior incubated with Cy2-con-
jugated goat anti-rabbit IgG. The images were captured by
using an Olympus IX-70 inverted fluorescence micro-
scope outfitted with a Hamamatzu Orca charge-coupled
device and then analyzed with Image Pro software.
Statistics
One-way analyses of variance were performed followed by
Student-Newman-Keuls post-hoc tests using SigmaStat
v2.0 software or student T-test by Prism (GraphPad, San
Diego, CA). Significance was accepted at P < 0.05.
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